Abstract
RNA interference (RNAi) is a fundamental mechanism of gene regulation and has been harnessed to produce a new class of drugs for treatment of various diseases. A key issue in these applications is how to effectively deliver RNAi therapeutics into target cells. This review is focused on advances in RNA delivery in vivo. To achieve it, novel strategies have been developed to enhance stability of RNA in cells and tissues, overcome barriers to transport of RNA or its carriers in the body, and reduce immunogenicity and cytotoxicity of treatment. Approaches to RNA delivery are divided into three categories in this review: biological, chemical, and physical. Advantages and disadvantages of each method are discussed. At present, effective delivery of RNAi therapeutics in vivo is still a challenge although significant advances have been made in this field.
Keywords: RNA interference, RNA delivery, physiological barriers, transport.
Current Pharmaceutical Biotechnology
Title:Critical Issues in Delivery of RNAi Therapeutics In Vivo
Volume: 13 Issue: 7
Author(s): Stephanie Rivera and Fan Yuan
Affiliation:
Keywords: RNA interference, RNA delivery, physiological barriers, transport.
Abstract: RNA interference (RNAi) is a fundamental mechanism of gene regulation and has been harnessed to produce a new class of drugs for treatment of various diseases. A key issue in these applications is how to effectively deliver RNAi therapeutics into target cells. This review is focused on advances in RNA delivery in vivo. To achieve it, novel strategies have been developed to enhance stability of RNA in cells and tissues, overcome barriers to transport of RNA or its carriers in the body, and reduce immunogenicity and cytotoxicity of treatment. Approaches to RNA delivery are divided into three categories in this review: biological, chemical, and physical. Advantages and disadvantages of each method are discussed. At present, effective delivery of RNAi therapeutics in vivo is still a challenge although significant advances have been made in this field.
Export Options
About this article
Cite this article as:
Rivera Stephanie and Yuan Fan, Critical Issues in Delivery of RNAi Therapeutics In Vivo, Current Pharmaceutical Biotechnology 2012; 13 (7) . https://dx.doi.org/10.2174/138920112800624300
DOI https://dx.doi.org/10.2174/138920112800624300 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Adult Treatment Informed By Transference-Countertransference Phenomena Typical For Adolescents
Adolescent Psychiatry Lipid Management for the Prevention of Cardiovascular Disease
Current Pharmaceutical Design A High Burden of Ischemic Stroke in Regions of Eastern/Central Europe is Largely Due to Modifiable Risk Factors
Current Neurovascular Research Editorial [ Hot Topic: Current Topics on the Epidemiology, Pathogenesis, and Treatment of Diabetes Mellitus and its Complications (Guest Editors: Moses S. Elisaf and Evangelos C. Rizos)]
Current Vascular Pharmacology Avian Genomes: Important Resources for Understanding Vertebrate Biology
Current Genomics Clinical Profile of Relaxin, a Possible New Drug for Human Use
Current Drug Safety Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design Secondary Hypertension: The Ways of Management
Current Vascular Pharmacology Review of Rational Approaches to the Treatment of Pain Management-Role forOpioids Therapies
Current Drug Therapy Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics
Current Medicinal Chemistry - Central Nervous System Agents IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews Fluorescent Probes for Cellular Assays
Combinatorial Chemistry & High Throughput Screening Genetics of Hypertrophic and Dilated Cardiomyopathy
Current Pharmaceutical Biotechnology Reversal of Informational Entropy and the Acquisition of Germ-like Immortality by Somatic Cells
Current Aging Science Targeting the Kinetochore in Cancer Therapy: The Ndc80/Hec1 Complex
Current Drug Therapy Will Antirheumatic Treatment Improve Cardiovascular Outcomes in Patients with Rheumatoid Arthritis?
Current Pharmaceutical Design Atypical GTPases as Drug Targets
Anti-Cancer Agents in Medicinal Chemistry Cardiovascular Effects of Green Tea Catechins: Progress and Promise
Recent Patents on Cardiovascular Drug Discovery Cancer, Signal Transduction and Nanotechnology
Current Drug Delivery